Congenital absence, atresia and stenosis of small intestine

Q17_CONGEN_ABSENCE_ATRES_STENO_SMALL_INTESTINE

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — Q41 Cause of death: ICD-10 — Q41 2 out of 7 registries used, show all original rules.	44
4. Check minimum number of events None	44
5. Include endpoints None	44
6. Filter based on genotype QC (FinnGen only)	44

Control definitions (FinnGen only)

Control exclude: Q17_OTHER_CONGEN_MALFO_DIGES_SYSTEM1

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: Q3[8-9]|Q4[0-5]
Name in latin: Agenesis, atresia sive stenosis congenita intestini tenuis

NAME	Q17_CONGEN_ABSENCE_ATRES_STENO_SMALL_INTESTINE
CONTROL_EXCLUDE	Q17_OTHER_CONGEN_MALFO_DIGES_SYSTEM1
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	Q41
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	Q41
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Congenital absence, atresia and stenosis of small intestine based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	712	399	312
Only index persons	450	249	201
Unadjusted period prevalence (%)
Whole population	0.01	0.01	0.01
Only index persons	0.01	0.01	0.01
Median age at first event (years)
Whole population	0.06	0.01	0.01
Only index persons	0.37	0.53	0.16

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	44	33	11
Unadjusted period prevalence (%)	0.01	0.01	0.00
Median age at first event (years)	5.76	6.41	3.81

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

No data available

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(40768797) Stomach Pathology biopsy report

12.23

14.89

2.1

1.2

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

11.38

9.80

10.6

2.5

29.59

2.89

umol/l

—

(3044640) Blood type and Crossmatch panel - Blood

5.67

7.55

5.6

2.6

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

21.96

6.56

4.8

14.8

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

21.96

6.56

11.7

2.2

1.31

1.50

umol/l

—

(3042936) Bacteria identified in Isolate by Culture

5.56

5.85

1.9

1.6

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

102

4.35

5.47

22.2

5.7

35.21

36.52

g/l

0.46

(3023368) Bacteria identified in Blood by Culture

4.49

5.13

6.4

3.5

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

5.76

5.09

17.2

16.7

1.03

1.09

mg/l

0.18

(4035726)

10.91

5.05

2.0

1.7

—

(3016038) Potassium [Moles/volume] in Urine

16.21

4.74

7.3

3.0

48.14

25.20

mmol/l

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

11.84

4.73

1.5

1.7

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

3.98

4.69

6.6

2.1

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

4.31

4.54

22.8

4.6

6.33

6.62

umol/l

0.04

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

3.94

4.54

4.9

3.0

2.60

0.84

e6/l

0.39

(36304419) Bacteria [Presence] in Urine

106

3.77

4.49

7.0

2.8

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

4.89

4.26

16.9

3.6

47.00

44.73

ng/l

0.09

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

3.78

4.19

4.8

3.0

8.31

1.90

e6/l

0.60

(3020717) Zinc [Moles/volume] in Serum or Plasma

13.54

3.87

6.0

1.2

12.47

29.04

umol/l

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

157

3.47

3.76

7.4

4.5

—

(3022145) Colonoscopy Study observation

4.67

3.74

2.0

1.4

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

3.80

3.69

10.1

4.9

30.21

29.87

0.10

(3020393) Adenovirus Ag [Presence] in Stool

11.27

3.60

1.3

1.7

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

5.84

3.21

2.4

1.7

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

6.68

3.15

2.1

2.3

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

3.40

3.15

16.9

7.8

23.29

23.47

mmol/l

0.10

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

118

2.98

3.11

11.5

3.2

—

(3000991) Gas panel - Venous blood

3.33

3.05

31.1

9.5

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

6.16

2.99

22.7

4.3

60.79

51.17

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

3.01

2.98

5.4

2.4

51.61

52.62

u/l

0.05

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

5.17

2.95

14.4

8.8

2.66

3.06

g/l

—

(3036489) Thrombin time

4.88

2.83

14.1

7.1

22.13

22.16

—

(3002256) Pathology report gross observation

4.24

2.75

1.6

1.2

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

4.63

2.71

14.6

6.4

236.00

152.45

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

101

2.79

2.70

16.4

3.3

40.40

32.28

u/l

0.61

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

125

2.75

2.70

12.1

2.2

67.37

70.30

nmol/l

0.27

112

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

7.84

2.61

1.6

3.0

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

7.84

2.61

1.6

5.7

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

4.97

2.59

2.6

1.7

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

4.67

2.47

1.1

—

(3025941) Bacteria identified in Stool by Culture

4.67

2.47

1.9

1.2

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

6.08

2.27

1.4

1.3

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2.68

2.23

53.4

9.7

24.83

24.42

mmol/l

0.28

(42870588) Differential panel, method unspecified - Blood

143

2.48

2.23

16.3

7.4

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

4.77

2.23

5.3

17.3

1.12

0.95

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

201

2.54

2.13

19.1

5.4

149.47

107.22

u/l

1.20

194

(3014148) Varicella zoster virus Ab [Titer] in Serum

5.46

2.12

1.4

1.3

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2.51

2.11

11.6

1.5

2.68

2.40

mg/l

0.32

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

2.64

2.08

35.9

7.1

24.16

24.15

mmol/l

0.00

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

165

2.40

2.06

45.7

7.5

1.23

mmol/l

0.04

149

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

3.38

2.05

2.4

5.1

197.50

246.74

u/l

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

3.25

1.97

14.9

7.5

102.88

82.86

—

(3022313) Gas panel - Capillary blood

2.55

1.96

37.9

6.8

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

3.90

1.90

2.7

1.6

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

3.68

1.81

15.8

14.4

120.67

131.06

g/l

—

(3006504) Eosinophils/100 leukocytes in Blood

204

2.23

1.67

15.4

6.7

3.02

3.06

0.04

193

(3019069) Monocytes/100 leukocytes in Blood

206

2.19

1.60

15.7

7.0

9.24

7.97

1.55

197

(3022096) Basophils/100 leukocytes in Blood

197

2.15

1.58

15.8

7.1

0.51

0.61

0.48

189

(40761535) Cells panel - Urine sediment

3.61

1.56

14.0

2.7

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

3.13

1.56

2.2

1.8

—

(3026008) Bacteria identified in Urine by Culture

2.16

1.55

2.5

2.2

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

2.98

1.48

1.8

2.1

—

(40768804) Tissue Pathology biopsy report

2.04

1.33

3.3

1.8

—

(3009508) Creatinine [Moles/volume] in Urine

2.06

1.27

7.0

3.6

4.86

7.79

mmol/l

2.11

(3002030) Lymphocytes/100 leukocytes in Blood

218

1.96

1.24

15.5

6.5

34.72

34.60

0.02

209

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2.12

1.23

10.8

3.3

0.81

0.71

mg/l

0.10

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

2.50

1.23

2.8

2.5

430.83

141.65

ng/l

—

(3048689) Calprotectin [Mass/mass] in Stool

2.07

1.22

8.9

1.6

81.08

55.41

ug/g

0.33

(3019550) Sodium [Moles/volume] in Serum or Plasma

334

2.45

1.22

46.2

10.4

138.72

139.41

mmol/l

1.43

321

(3048929) Epstein Barr virus Ab [Presence] in Serum

2.32

1.11

2.4

1.5

—

(3018010) Neutrophils/100 leukocytes in Blood

213

1.86

1.10

15.3

6.4

49.60

50.97

0.22

203

(3007853) Bacteria identified in Skin by Aerobe culture

2.09

1.09

3.0

1.3

—

(3021589) Normoblasts [#/volume] in Blood

196

1.79

1.03

23.3

7.8

0.00

e9/l

0.00

150

(40758558) Short blood count panel - Blood

106

1.80

0.96

10.1

3.7

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

199

1.74

0.95

17.4

6.7

5.89

5.94

mmol/l

0.06

178

(3044889) 12 lead EKG panel

152

1.72

0.93

2.0

2.5

—

(3003694) ABO and Rh group [Type] in Blood

153

1.71

0.90

2.1

1.7

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1.87

0.82

1.1

1.7

—

(3007461) Platelets [#/volume] in Blood

415

+∞

0.82

50.8

14.2

280.50

266.75

e9/l

0.39

403

(3001122) Ferritin [Mass/volume] in Serum or Plasma

177

1.62

0.77

8.8

2.6

63.78

49.86

ug/l

0.47

164

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1.83

0.74

2.1

1.9

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

100

0.54

0.73

1.8

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1.79

0.72

2.1

1.8

—

(3037522) Nuclear Ab [Titer] in Serum

1.70

0.68

1.0

1.8

—

501.82

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1.69

0.65

2.5

1.9

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1.60

0.64

5.9

3.2

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

1.75

0.63

3.2

1.5

—

(3010813) Leukocytes [#/volume] in Blood

417

+∞

0.61

50.8

14.1

7.08

7.41

e9/l

0.33

405

(3026361) Erythrocytes [#/volume] in Blood

416

+∞

0.60

50.9

14.1

4.42

4.51

e12/l

0.55

404

(3019832) Treponema pallidum Ab [Presence] in Serum

109

0.57

0.58

1.6

1.7

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

157

1.50

0.57

61.4

9.3

1.23

1.24

mmol/l

0.43

148

(3017143) Hepatitis C virus Ab [Presence] in Serum

1.51

0.56

1.3

1.5

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

247

1.50

0.55

16.9

6.7

99.35

103.50

ml/min/173m2

0.50

163

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

358

1.76

0.52

36.3

9.9

25.23

22.79

mg/l

0.17

254

(3013139) Helicobacter pylori Ag [Presence] in Stool

0.00

0.42

0.0

1.0

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

0.00

0.42

0.0

1.7

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

0.00

0.42

0.0

1.3

—

1.30

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

0.00

0.42

0.0

1.3

—

0.23

—

(40760892) CBC W Ordered Manual Differential panel - Blood

1.47

0.41

14.4

5.5

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

162

0.72

0.37

2.2

1.8

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

354

1.52

0.37

3.9

4.0

—

(3013512) EKG study

1.35

0.34

2.5

2.2

—

(3015736) pH of Urine

151

1.32

0.31

5.1

2.9

—

(3019150) Specific gravity of Urine by Refractometry

1.39

0.31

5.7

3.0

—

1.02

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1.29

0.28

1.3

1.9

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

0.70

0.27

1.5

—

(3002385) Erythrocyte distribution width [Ratio]

357

1.45

0.27

44.5

12.2

14.02

13.25

1.86

352

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1.21

0.22

2.0

2.4

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

0.00

0.21

0.0

1.2

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

0.00

0.21

0.0

3.2

—

23.66

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

0.00

0.21

0.0

1.4

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

0.00

0.21

0.0

1.2

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

0.00

0.21

0.0

1.2

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.21

0.0

1.5

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

0.00

0.21

0.0

1.2

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

0.00

0.20

0.0

1.1

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

0.00

0.20

0.0

1.1

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

120

0.78

0.20

1.9

1.7

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

150

0.81

0.19

2.0

—

(3037467) Urinalysis macro (dipstick) panel - Urine

249

1.21

0.18

9.3

3.5

—

(3012516) Albumin [Mass/volume] in Urine

1.10

0.10

6.8

2.8

18.20

434.80

mg/l

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1.07

0.10

7.0

3.2

3.46

52.92

mg/mmol

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

117

1.15

0.09

2.2

2.5

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

112

0.86

0.08

2.2

2.3

—

(1761868) Lipid panel - Serum or Plasma

0.86

0.08

2.1

1.9

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

0.86

0.08

3.3

2.3

228.86

298.51

u/l

—

(3013707) Erythrocyte sedimentation rate by Westergren method

237

1.12

0.08

8.7

3.2

6.76

8.54

mm/h

0.78

221

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

124

1.07

0.00

6.2

2.9

—

(3007164) IgA [Mass/volume] in Serum or Plasma

132

0.98

0.00

2.1

1.5

2.69

1.55

g/l

—

(3041096) Erythrocytes [Presence] in Urine by Automated

0.91

0.00

4.1

2.5

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.0

1.0

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

0.00

0.0

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.0

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.0

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

0.00

0.0

1.7

—

(44813793)

0.00

0.0

1.2

—

(3004616) Nuclear Ab [Presence] in Serum

0.00

0.0

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.0

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

0.00

0.0

1.5

—

206.00

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1.02

0.00

4.0

4.8

862.00

932.99

ng/l

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

0.00

0.0

1.4

—

71.90

—

(40768793) Breast Pathology biopsy report

0.00

0.0

1.0

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

0.00

0.0

2.2

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

0.00

0.0

1.5

—

(3004588) Protein electrophoresis panel - Serum or Plasma

0.00

0.0

1.0

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

0.00

0.0

1.3

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(36660697) Celiac disease serology panel - Serum

1.00

0.00

1.8

1.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.4

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.0

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.0

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

0.00

0.0

1.0

—

108.83

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

0.00

0.0

1.6

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

0.00

0.0

11.0

—

770.00

—

(4198724)

0.00

0.0

2.2

—

(3023420) DNA double strand Ab [Units/volume] in Serum

0.00

0.0

2.0

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

0.00

0.0

1.4

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.00

0.0

4.3

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.0

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

0.00

0.0

1.5

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

0.00

0.0

1.0

—

(3029075) Extractable nuclear Ab panel - Serum

0.00

0.0

1.0

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

0.00

0.0

1.2

—

23.74

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

0.00

0.0

12.8

—

1567.00

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

0.00

0.0

5.7

—

399.71

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

0.00

0.0

1.7

—

(3035933) Granulocytes/100 leukocytes in Blood

0.00

0.0

1.4

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

0.36

—

Mortality – FinRegistry

↥

Association

Association between endpoint Q17_CONGEN_ABSENCE_ATRES_STENO_SMALL_INTESTINE and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have Q17_CONGEN_ABSENCE_ATRES_STENO_SMALL_INTESTINE.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: Q17_CONGEN_ABSENCE_ATRES_STENO_SMALL_INTESTINE – Congenital absence, atresia and stenosis of small intestine

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Congenital absence, atresia and stenosis of small intestine

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints